Bradley Allen Kreger Velo3 D, Inc. (VLD) insider trading activity

Bradley Allen Kreger is COO of Velo3D, Inc.. Currently has a direct ownership of 65,359 shares of VLD, which is worth approximately $48,365. The most recent transaction as insider was on May 15, 2025, when has been sold 22,759 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.4K

7616.53% 3M change

71.96% 12M change

Total Value Held $48,365

Bradley Allen Kreger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2025	SELL Payment of exercise price or tax liability	-	22,759 Reduced 25.83%	65,359 Common Stock
May 15 2025	BUY Exercise of conversion of derivative security	-	55,398 Added 38.85%	87,183 Common Stock
Mar 15 2025	SELL Open market or private sale	-	6,710 Reduced 41.08%	9,623 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	16,333 Added 33.3%	32,720 Common Stock
Feb 15 2025	SELL Open market or private sale	-	936 Reduced 52.5%	847 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	2,274 Added 8.96%	23,097 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 4.91%	17,387 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 4.91%	17,387 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	6,591 Added 28.56%	16,489 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	6,591 Added 28.56%	16,489 Common Stock
Oct 18 2024	SELL Open market or private sale	$289 $0.85 p/Share	341 Reduced 3.22%	10,261 Common Stock
Oct 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 7.81%	10,602 Common Stock
Sep 18 2024	SELL Open market or private sale	$163 $0.45 p/Share	363 Reduced 3.74%	9,341 Common Stock
Sep 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 8.47%	9,704 Common Stock
Aug 20 2024	SELL Open market or private sale	$430 $1.24 p/Share	347 Reduced 3.94%	8,459 Common Stock
Aug 18 2024	BUY Exercise of conversion of derivative security	-	899 Added 9.26%	8,806 Common Stock
Aug 16 2024	SELL Open market or private sale	$457 $1.25 p/Share	366 Reduced 4.42%	7,907 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	835 Added 9.17%	8,273 Common Stock
Jul 19 2024	SELL Open market or private sale	$1,040 $3.05 p/Share	341 Reduced 4.38%	7,438 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	-	899 Added 10.36%	7,779 Common Stock
Jun 27 2024	SELL Open market or private sale	$1,033 $3.16 p/Share	327 Reduced 4.33%	7,229 Common Stock
Jun 18 2024	BUY Exercise of conversion of derivative security	-	899 Added 10.63%	7,556 Common Stock
May 20 2024	SELL Open market or private sale	$2,371 $0.2 p/Share	11,859 Reduced 4.84%	233,051 Common Stock
May 18 2024	BUY Exercise of conversion of derivative security	-	31,446 Added 11.38%	244,910 Common Stock
May 15 2024	SELL Open market or private sale	$2,469 $0.23 p/Share	10,735 Reduced 4.79%	213,464 Common Stock

Also insider at

LAB

STANDARD BIOTOOLS INC. Healthcare

SVP, Global Operations

BAK